Three faculty positions at UBC to advance the cell therapies program

Now Hiring! Applications will be accepted until the position is filled
The UBC Faculty of Medicine is performing an international search to recruit three faculty positions to support this program: A global leader (UBC Chair) who will establish an ambitious research program and lead the integration of relevant expertise across the province to drive the development of novel cell therapies for MS, and two biomedical engineers with complementary expertise who will be active members of the Network and work closely with the UBC Chair to advance therapeutic discoveries.
We are looking for early and/or mid, and advanced career candidates for the following faculty positions that are open to all applicants with a PhD, and/or MD, or equivalent academic qualifications:
- One established investigator (Full Professor) with expertise in MS and experience in immunotherapy and/or cell therapy
- One emerging investigator (Assistant Professor) with expertise in neuro-engineering*
- One emerging investigator (Assistant Professor) with expertise in immuno-engineering*
*For appointments to the School of Biomedical Engineering, consideration will be given to candidates who hold a P.Eng. licence or who are eligible to obtain a P.Eng. license and consequently register for one with Engineers and Geoscientists BC. Individuals with quantitative science backgrounds such as Math, Computer Science, or Physics are also encouraged to apply if they are eligible for a Limited Licence with Engineers and Geoscientists BC (see https://www.egbc.ca/Registration/Individual-Registrants/How-to-Apply/Professional-Registration/Professional-Licensee for details on the Limited Licence).
Successful candidates will be primarily housed within the Faculty of Medicine and/or Faculty of Applied Science in the Department of Medicine and/or the School of Biomedical Engineering. An appropriate academic unit will be identified at the time the successful candidates are selected, contingent upon the candidates’ area of expertise.
News & updates
-
$3 million Breakthrough Prize goes to scientists that completely changed our understanding of multiple sclerosis
-
CAR T Cell Therapies With Autoimmune Readouts
-
Transforming Health Symposium
-
SBME Symposium 2024
-
Blood biomarker reveals signs of multiple sclerosis years before
-
Life-saving CAR-T cancer therapy now being provided in British Columbia
-
UBC and the BC biotech boom
-
CAR-T therapy for multiple sclerosis enters US trials for first time
-
Register for ISCT in Vancouver – May 29-June 1
-
Kyverna Therapeutics Eyes IPO Amid Rising Interest in CAR-T Therapy for Autoimmune Diseases
-
CHOP’s on-site production could lower high cost of gene therapies
-
CAR-T therapy offers new hope to multiple sclerosis patients